Shomron Ben‐Horin

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Jean‐François Rahier, Fernando Magro, Cândida Abreu et al. · Journal of Crohn s and Colitis · 2014 · 921 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

Bruce E. Sands, Brian G. Feagan, Paul Rutgeerts et al. · Gastroenterology · 2014 · 705 citations · Full text

Medicine, Immunology, Pharmacology +15

Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial

Alon Lang, Nir Salomon, Justin CY Wu et al. · Clinical Gastroenterology and Hepatology · 2015 · 422 citations

Pharmacy, Pharmacotherapy, Gastroenterology +12

Optimizing Anti-TNF-α Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases

Bella Ungar, Idan Levy, Yarden Yavne et al. · Clinical Gastroenterology and Hepatology · 2015 · 363 citations

Veterinary Medicine, Immunology, Pharmacotherapy +17

Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects

Matthieu Allez, Konstantinos Κarmiris, Édouard Louis et al. · Journal of Crohn s and Colitis · 2010 · 337 citations · Full text

Medicine, Immunology, Pharmacology +15